CMV infection in HSCT recipients
Research type
Research Study
Full title
Analysis of the Burden of Cytomegalovirus Infection and Disease in Hematopoietic Stem Cell Transplant Recipients.
IRAS ID
237860
Contact name
Eduardo Olavarria
Contact email
Sponsor organisation
Merck Sharp & Dohme Limited
Duration of Study in the UK
0 years, 11 months, 31 days
Research summary
In this single-centre, retrospective, observational study, we will explore the incidence of CMV reactivation and disease in patients undergoing allogeneic stem cell transplantation. We will analyze the dynamics of PCR values and the response to the different treatment options. Finally, we will evaluate the health economics associated with CMV infection in this setting.
REC name
London - City & East Research Ethics Committee
REC reference
17/LO/1994
Date of REC Opinion
24 Nov 2017
REC opinion
Favourable Opinion